Genetic Testing Reveals Why Mediterranean Diet Works Better for Some People

Atherosclerosis remains a leading cause of cardiovascular death worldwide, but emerging research suggests that personalized nutrition based on individual genetic profiles could revolutionize prevention strategies. This systematic review examined how genetic variants, gut microbiome composition, and metabolic markers influence responses to dietary interventions for atherosclerosis management.

Researchers analyzed 14 high-quality studies involving over 15,000 participants across multiple countries. The studies employed various designs including randomized controlled trials and genetic interaction studies, focusing on how individual biological characteristics modify responses to specific dietary patterns like the Mediterranean diet and omega-3 supplementation.

The most striking finding was the significant variability in how people respond to the same dietary interventions based on their genetic makeup. For example, polymorphisms in the APOA2 gene influenced how body mass index and lipid levels responded to dietary changes. Similarly, variants in genes like PLA2G2A, PLA2G2C, and MGLL determined whether individuals experienced beneficial changes in triglycerides and LDL cholesterol following omega-3 supplementation. Some participants showed dramatic improvements while others showed minimal response to identical interventions.

The research also revealed that omega-3 fatty acids can modulate microRNA expression, affecting lipid metabolism pathways. Epigenetic studies demonstrated that dietary components modify gene expression related to inflammation and lipid metabolism through histone acetylation and non-coding RNA activity. These molecular mechanisms help explain why personalized approaches based on individual genetic profiles could be more effective than standard dietary guidelines.

These findings have profound implications for cardiovascular disease prevention. Rather than applying universal dietary recommendations, clinicians could potentially use genetic testing to identify which patients would benefit most from specific interventions like Mediterranean diet patterns or omega-3 supplementation. This precision approach could improve treatment outcomes while reducing healthcare costs by avoiding ineffective interventions. However, the field requires standardized protocols and larger validation studies before widespread clinical implementation.